COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 2 of 4 for:    POLO | Pancreatic Cancer

Gemcitabine or Gemcitabine and Cisplatin in the Treatment of Advanced Pancreatic Cancer (GIP-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00813696
Recruitment Status : Unknown
Verified December 2008 by Istituti Tumori Giovanni Paolo II.
Recruitment status was:  Active, not recruiting
First Posted : December 23, 2008
Last Update Posted : December 23, 2008
Gruppo Oncologico Italia Meridionale
Gruppo Italiano per lo studio dei Carcinomi dell'Apparato Digerente
Gruppo Oncologico Italiano di Ricerca Clinica
Cattedra di Endocrinochirurgia, Università di Verona
Information provided by:
Istituti Tumori Giovanni Paolo II